PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
S-(tricyclo(5.2.1.0'2,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate
X4261
|
401-850-9 | 255881-94-8 | 1 | 1 | - | - | 1 | - | 2 | 1 | - | Details |
| S-allyl O-pentyl dithiocarbonate | 220-977-9 | 2956-12-9 | - | - | 1 | - | - | - | - | - | - | Details |
|
S-benzyl N,N-dipropylthiocarbamate
PROSULFOCARB
|
401-730-6 | 52888-80-9 | - | - | - | - | 1 | 1 | - | - | - | Details |
| S-ethyl N-cyclohexylthiocarbamate | 214-482-7 | 1134-23-2 | - | - | 1 | - | 1 | - | - | - | - | Details |
| S-metolachlor (ISO); 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide; (RaSa)-2-chloro-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]acetamide | 618-004-1 | 87392-12-9 | - | - | - | - | - | 1 | - | - | - | Details |
| Saccharides of mannose and galactose from Ceratonia Siliqua seed | 946-767-3 | - | - | - | - | - | 1 | - | - | - | - | Details |
| Saccharomyces cerevisiae cell wall, extracted | 949-711-6 | - | - | - | 1 | - | - | - | - | - | - | Details |
|
Saccharomyces cerevisiae, ext.
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Saccharomyces cerevisiae, Saccharomycelaceae.
|
283-294-5 | 84604-16-0 | - | - | 1 | - | - | - | - | - | - | Details |
| Saccharomyces cerevisiae, lysate | 305-230-8 | 94350-12-6 | - | - | 2 | - | - | - | - | - | - | Details |
| Salicylic acid | 200-712-3 | 69-72-7 | - | - | - | 1 | 1 | 1 | - | - | - | Details |